BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37934524)

  • 1. Trends in Cannabis-positive Urine Toxicology Test Results: US Veterans Health Administration Emergency Department Patients, 2008 to 2019.
    Fink DS; Malte C; Cerdá M; Mannes ZL; Livne O; Martins SS; Keyhani S; Olfson M; McDowell Y; Gradus JL; Wall MM; Sherman S; Maynard CC; Saxon AJ; Hasin DS
    J Addict Med; 2023 Nov-Dec 01; 17(6):646-653. PubMed ID: 37934524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cannabis Legalization with Cannabis Positive Drug Screening in US Veterans.
    Fink DS; Samples H; Malte CA; Olfson M; Wall MM; Alschuler DM; Saxon AJ; Hasin DS
    medRxiv; 2023 Dec; ():. PubMed ID: 38105937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019.
    Hasin DS; Saxon AJ; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Wall MM
    Am J Psychiatry; 2022 Oct; 179(10):748-757. PubMed ID: 35899381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019.
    Hasin DS; Wall MM; Alschuler D; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    medRxiv; 2023 Jul; ():. PubMed ID: 37503049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study.
    Hasin DS; Wall MM; Alschuler DM; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    Lancet Psychiatry; 2023 Nov; 10(11):877-886. PubMed ID: 37837985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
    Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
    JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of women concordant and discordant for urine drug screens for cannabis exposure and self-reported cannabis use during pregnancy.
    Bogdan R; Leverett SD; Constantino-Petit AM; Lashley-Simms N; Liss DB; Johnson EC; Lenze SN; Lean RE; Smyser TA; Carter EB; Smyser CD; Rogers CE; Agrawal A
    Neurotoxicol Teratol; 2024; 103():107351. PubMed ID: 38604316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics.
    Ruglass LM; Shevorykin A; Zhao Y; Killeen TK; Bauer AG; Morgan-López AA; Back SE; Fitzpatrick S; López-Castro T; Norman SB; Saavedra LM; Hien DA
    Drug Alcohol Depend; 2023 Mar; 244():109769. PubMed ID: 36696843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration.
    Williams EC; Fletcher OV; Frost MC; Harris AHS; Washington DL; Hoggatt KJ
    JAMA Netw Open; 2022 Jun; 5(6):e2219651. PubMed ID: 35771574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws.
    Martins SS; Segura LE; Levy NS; Mauro PM; Mauro CM; Philbin MM; Hasin DS
    JAMA Netw Open; 2021 Sep; 4(9):e2127002. PubMed ID: 34570205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019.
    Mannes ZL; Malte CA; Olfson M; Wall MM; Keyes KM; Martins SS; Cerdá M; Gradus JL; Saxon AJ; Keyhani S; Maynard C; Livne O; Fink DS; Gutkind S; Hasin DS
    Pain; 2023 Sep; 164(9):2093-2103. PubMed ID: 37159542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019.
    Livne O; Malte CA; Olfson M; Wall MM; Keyes KM; Maynard C; Gradus JL; Saxon AJ; Martins SS; Keyhani S; McDowell Y; Fink DS; Mannes ZL; Gutkind S; Hasin DS
    Am J Psychiatry; 2024 Feb; 181(2):144-152. PubMed ID: 38018141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the U Stand for Useless? The Urine Drug Screen and Emergency Department Psychiatric Patients.
    Riccoboni ST; Darracq MA
    J Emerg Med; 2018 Apr; 54(4):500-506. PubMed ID: 29500048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in emergency department visits associated with cannabis use among older adults in California, 2005-2019.
    Han BH; Brennan JJ; Orozco MA; Moore AA; Castillo EM
    J Am Geriatr Soc; 2023 Apr; 71(4):1267-1274. PubMed ID: 36622838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate Utilization of Urine Drug Screen Nationwide in the Evaluation of Acute Chest Pain.
    Overbeek DL; Janke AT; Watson CJ; Salhi RA; Kim E; Boatright D; Losman ED
    West J Emerg Med; 2023 Mar; 24(2):135-140. PubMed ID: 36976604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine abuse in emergency department patients undergoing psychiatric evaluation.
    Pomerleau AC; Sutter ME; Owen KP; Loomis E; Albertson TE; Diercks DB
    J Emerg Med; 2012 Nov; 43(5):798-802. PubMed ID: 22538120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapidly increasing trend of cannabis use in burn injury.
    Jehle CC; Nazir N; Bhavsar D
    J Burn Care Res; 2015; 36(1):e12-7. PubMed ID: 25412052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in COVID-19-Related Testing and Healthcare Utilization by Race and Ethnicity in the Veterans Health Administration.
    Razjouyan J; Helmer DA; Li A; Naik AD; Amos CI; Bandi V; Sharafkhaneh A
    J Racial Ethn Health Disparities; 2022 Apr; 9(2):519-526. PubMed ID: 33694124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of urine drug screening in the medical clearance of pediatric psychiatric patients: is there one?
    Shihabuddin BS; Hack CM; Sivitz AB
    Pediatr Emerg Care; 2013 Aug; 29(8):903-6. PubMed ID: 23903675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Rates of Suicide Risk Screening and Prevalence of Positive Screening Results Among US Veterans After Implementation of the Veterans Affairs Suicide Risk Identification Strategy.
    Bahraini N; Brenner LA; Barry C; Hostetter T; Keusch J; Post EP; Kessler C; Smith C; Matarazzo BB
    JAMA Netw Open; 2020 Oct; 3(10):e2022531. PubMed ID: 33084900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.